Rybelsus 14 Mg 10 Tablets

Rybelsus 14 Mg 10 Tablets

Description:

Rybelsus 14 mg is an oral prescription diabetes medicine containing semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes mellitus. It is taken once daily as tablets and is typically used together with diet and exercise, and may be combined with other antidiabetic medications when prescribed by a healthcare professional. Rybelsus helps enhance glucose-dependent insulin secretion, reduce inappropriate glucagon release, and slow gastric emptying, supporting better glycemic control and long-term diabetes management.

Indications:

• Management of type 2 diabetes mellitus in adults to improve glycemic control.
• Helps lower elevated fasting and postprandial blood glucose levels.
• May be used as monotherapy when metformin is not tolerated or contraindicated, or as add-on therapy to other oral antidiabetic agents or insulin as directed by a physician.
• Supports reduction of diabetes-related complications when used as part of a comprehensive treatment plan including diet, exercise, and regular medical follow-up.

Active Ingredients / Key Components:

• Semaglutide – 14 mg per tablet.
• Inactive ingredients/excipients: Full excipient list and their concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the official package leaflet for complete details.

Dosage & Administration / How to Use:

• Rybelsus is for oral use only and must be taken exactly as prescribed by your doctor.
• Typical regimen: treatment is usually initiated with a lower strength (such as 3 mg or 7 mg once daily) and then increased to 14 mg once daily as maintenance dose, according to medical advice. Do not start or change dose without consulting your physician.
• Take one 14 mg tablet once daily on an empty stomach, at least 30 minutes before eating, drinking (other than up to half a glass of plain water), or taking any other oral medicines.
• Swallow the tablet whole with up to half a glass of plain water (not more than 120 ml). Do not split, crush, or chew the tablet.
• Try to take Rybelsus at the same time every day to maintain consistent blood levels.
• If you miss a dose and it is more than 30 minutes since you last ate or drank, you may take the tablet as soon as you remember, then continue with your regular schedule the next day. Do not take an extra tablet or double dose to make up for a missed dose.
• Use in combination with other antidiabetic medicines (e.g., insulin, sulfonylureas) may require dose adjustment of those medicines to reduce risk of hypoglycemia; follow your doctor’s instructions.
• Not recommended for use in type 1 diabetes or for the treatment of diabetic ketoacidosis.

Clinical Benefits:

• Improves glycemic control in adults with type 2 diabetes by enhancing glucose-dependent insulin secretion and reducing inappropriate glucagon release.
• Helps lower fasting and post-meal blood sugar levels, contributing to better HbA1c reduction when used as directed.
• Once-daily oral tablet formulation offers a non-injectable GLP-1 option for patients who prefer tablets over injections.
• Slows gastric emptying, which can help reduce rapid spikes in blood glucose after meals.
• As a GLP-1 receptor agonist, it may support modest weight reduction in some patients with type 2 diabetes when combined with diet and lifestyle changes (individual results vary and it is not a standalone weight-loss medicine).

Warnings & Contraindications:

• Use only under medical supervision. Rybelsus is a prescription medicine for type 2 diabetes and is not suitable for self-medication.
• Contraindicated in patients with a known hypersensitivity to semaglutide or any of the excipients.
• Not indicated for type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
• Use with caution in patients with a history of pancreatitis; discontinue and seek medical attention if severe abdominal pain occurs that may radiate to the back.
• Use with caution in patients with severe gastrointestinal disease (e.g., severe gastroparesis) due to delayed gastric emptying effects.
• Monitor kidney function in patients with pre-existing renal impairment, especially if severe gastrointestinal adverse reactions (vomiting, diarrhea) occur, as these may lead to dehydration and worsen renal function.
• There may be a potential risk of thyroid C-cell tumors based on GLP-1 class data in animals; inform your doctor if you have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
• May increase risk of hypoglycemia when used with insulin or sulfonylureas; dose adjustment of these medicines may be required.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; safety data in pregnancy and lactation are limited, and alternative treatments may be preferred.
• Inform your doctor about all other medicines you are taking, including oral medications, as delayed gastric emptying may affect absorption of some drugs.
• Not intended to diagnose, treat, cure, or prevent any disease outside its approved indication for type 2 diabetes mellitus.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, diarrhea, abdominal pain, decreased appetite, indigestion, and constipation. These are often mild to moderate and may decrease over time as your body adjusts.
• Other possible side effects: headache, fatigue, dyspepsia, and mild weight loss.
• Serious side effects (seek immediate medical attention): signs of pancreatitis (severe, persistent abdominal pain that may radiate to the back, with or without vomiting), signs of allergic reaction (rash, itching, swelling of face, lips, tongue or throat, difficulty breathing), severe dehydration due to prolonged vomiting or diarrhea, or symptoms suggestive of thyroid problems (neck mass, hoarseness, difficulty swallowing, shortness of breath).
• This is not a complete list of side effects. Always read the patient information leaflet and consult your healthcare provider if you experience any unusual or persistent symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack in the original carton to protect from light. Do not store above the temperature specified in the official package insert (exact temperature range is not available in the provided information; refer to the leaflet). Keep container tightly closed and keep out of reach of children.

Specifications:

• Product form: Tablets.
• Strength: 14 mg semaglutide per tablet.
• Pack size: 10 tablets per pack.
• Route of administration: Oral.
• Intended use: Prescription antidiabetic medicine for adults with type 2 diabetes mellitus.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.